美国 · 平台与数据 · The Motley Fool
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility
Bristol Myers Squibb has led in seven of eight quarters, but Novo Nordisk's recent spike signals a shift worth watching for income-focused investors.
在 The Motley Fool 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.fool.com)



